Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure in Thailand.
Unchalee PermsuwanArintaya PhrommintikulVoratima SilavanichPublished in: ClinicoEconomics and outcomes research : CEOR (2020)
The use of CRT was associated with a cost-effectiveness ratio below generally accepted benchmarks for therapeutic interventions of 160,000 THB per QALY (5,156.30 USD per QALY). This suggests that the clinical benefits of CRT can be achieved at a reasonable cost in Thai HF patients.